Plasmodium mitochondrial electron transport chain

The **Plasmodium mitochondrial electron transport chain** is a multi-component, membrane-associated enzymatic pathway essential for the survival and development of Plasmodium species, including the malaria-causing Plasmodium falciparum. Unlike the mammalian ETC, Plasmodium ETC contains unique features such as a single-subunit type II NADH dehydrogenase and malate:quinone oxidoreductase, feeding electrons into the chain that consists of classic complexes III (cytochrome bc1 complex) and IV (cytochrome c oxidase). Its primary roles are to maintain electron flow for pyrimidine biosynthesis (via dihydroorotate dehydrogenase), generate a proton gradient for ATP synthesis during transmission stages, and support redox balance. The ETC is a validated therapeutic target; drugs such as atovaquone and endochin-like quinolones inhibit electron flow at Complex III, leading to parasite death or cytostatic arrest. Mutations conferring drug resistance and the need for high selectivity to avoid host mitochondrial toxicity remain key therapeutic challenges. The ETC's essentiality varies between parasite life cycle stages: in asexual blood stages, its main function is pyrimidine synthesis, while ATP generation via oxidative phosphorylation becomes critical in transmission stages[1][3][4][7][9].

Other names

Plasmodium ETCPlasmodium falciparum mitochondrial electron transport chainPlasmodium mETCPlasmodium mtETC

Inhibition of ubiquinone:cytochrome b binding (Complex III inhibitors, e.g., atovaquone, ELQs) Disruption of electron transfer through cytochrome complexes Collapse of the mitochondrial membrane potential Blockade of ubiquinone recycling, resulting in impaired pyrimidine biosynthesis Cytostatic growth arrest via mitochondrial dysfunction Selectivity via structural differences in Plasmodium ETC components vs. mammalian host ETC